The recent discovery of high ACE2 expression in pericytes in the heart opens a route to the possible infection of these cells by SARS-CoV-2 virus, with subsequent local microvascular dysfunction and coagulopathy that can contribute to the onset of venous thromboembolism, one of the most frequent cardiovascular complications in hospitalized COVID-19 patients [63]. Here, ACE2 is linked to infection.